Literature DB >> 8622661

Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.

D W White1, G A Pitoc, T D Gilmore.   

Abstract

The v-Rel oncoprotein of the avian Rev-T retrovirus is a member of the Rel/NF-kappa B family of transcription factors. The mechanism by which v-Rel malignantly transforms chicken spleen cells is not precisely known. To gain a better understanding of functions needed for transformation by v-Rel, we have now characterized the activities of mutant v-Rel proteins that are defective for specific protein-protein interactions. Mutant v-delta NLS, which has a deletion of the primary v-Rel nuclear localizing sequence, does not interact efficiently with I kappa B-alpha but still transforms chicken spleen cells approximately as well as wild-type v-Rel, indicating that interaction with I kappa B-alpha is not essential for the v-Rel transforming function. A second v-Rel mutant, v-SPW, has been shown to be defective for the formation of homodimers, DNA binding, and transformation. However, we now find that v-SPW can form functional DNA-binding heterodimers in vitro and in vivo with the cellular protein NF-kappa B p-52. Most strikingly, coexpression of v-SPW and p52 from a retroviral vector can induce the malignant transformation of chicken spleen cells, whereas expression of either protein alone cannot. Our results are most consistent with a model wherein Rel homodimers or heterodimers must bind DNA and alter gene expression in order to transform lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622661      PMCID: PMC231099          DOI: 10.1128/MCB.16.3.1169

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  Alterations at the rel locus in human lymphoma.

Authors:  D Lu; J D Thompson; G K Gorski; N R Rice; M G Mayer; J J Yunis
Journal:  Oncogene       Date:  1991-07       Impact factor: 9.867

2.  Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.

Authors:  A J Capobianco; T D Gilmore
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

3.  A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.

Authors:  G Mosialos; P Hamer; A J Capobianco; R A Laursen; T D Gilmore
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

4.  Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.

Authors:  R M Schmid; N D Perkins; C S Duckett; P C Andrews; G J Nabel
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

5.  vRel is an inactive member of the Rel family of transcriptional activating proteins.

Authors:  P M Richardson; T D Gilmore
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

6.  Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae.

Authors:  P J Morin; J A Downs; A M Snodgrass; T D Gilmore
Journal:  Cell Growth Differ       Date:  1995-07

Review 7.  Molecular mechanisms of transformation by the v-rel oncogene.

Authors:  M Hannink; H M Temin
Journal:  Crit Rev Oncog       Date:  1991

8.  Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway.

Authors:  C M Fan; T Maniatis
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

9.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.

Authors:  A Neri; C C Chang; L Lombardi; M Salina; P Corradini; A T Maiolo; R S Chaganti; R Dalla-Favera
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

10.  Rel-associated pp40: an inhibitor of the rel family of transcription factors.

Authors:  N Davis; S Ghosh; D L Simmons; P Tempst; H C Liou; D Baltimore; H R Bose
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

View more
  3 in total

1.  Mutational analysis of the v-Rel dimerization interface reveals a critical role for v-Rel homodimers in transformation.

Authors:  Andrew S Liss; Henry R Bose
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  LIM domain-containing protein trip6 can act as a coactivator for the v-Rel transcription factor.

Authors:  M K Zhao; Y Wang; K Murphy; J Yi; M C Beckerle; T D Gilmore
Journal:  Gene Expr       Date:  1999

3.  BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways.

Authors:  Jinming Yang; Katayoun I Amiri; James R Burke; Johannes A Schmid; Ann Richmond
Journal:  Clin Cancer Res       Date:  2006-02-01       Impact factor: 12.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.